Cargando…
Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae
Multidrug-resistant (MDR) bacterial pneumonia can induce dysregulated pulmonary and systemic inflammation leading to morbidity and mortality. Antibiotics to treat MDR pathogens do not function to modulate the extent and intensity of inflammation and can have serious side effects. Here we evaluate th...
Autores principales: | Holloway, Alex J., Yu, JiehJuen, Arulanandam, Bernard P., Hoskinson, Sarah M., Eaves-Pyles, Tonyia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826106/ https://www.ncbi.nlm.nih.gov/pubmed/29229643 http://dx.doi.org/10.1128/AAC.01900-17 |
Ejemplares similares
-
Combination of Cystatins 9 and C Modulates Serum Biomarkers Associated with Inflammation and Provides Prophylactic as Well as Long-Term Protection against Multidrug-Resistant Klebsiella pneumoniae
por: Holloway, Alex J., et al.
Publicado: (2019) -
New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada
por: Mulvey, Michael R., et al.
Publicado: (2011) -
New Delhi Metallo-β-Lactamase-1–Producing Klebsiella pneumoniae, Florida, USA
por: Li, Jun-Jie, et al.
Publicado: (2016) -
The New Delhi Metallo-Beta-Lactamases: Their Origins and Implication for the Intensivist
por: Chacko, Binila, et al.
Publicado: (2011) -
Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics
por: Zmarlicka, Monika T, et al.
Publicado: (2015)